Back to results
US 2022/0175790 A1Published application
Composition for treating carbapenem antibiotic-resistant acinetobacter baumannii infection
AssigneeGuangzhou Century Clinical Research Co., Ltd
InventorTianyu SUN
Life of this patent
Estimating the term…
Abstract
The application of a sulbactam and ceftazidime composition in the preparation of a drug for treating a carbapenem-resistant antibiotic Acinetobacter baumannii infection, characterized in the following: by mass, the amount of ceftazidime used in the sulbactam and ceftazidime composition comprising 10% to 90% of the amount of sulbactam used.
Claims13
A method of treating an infection with carbapenem antibiotic-resistant Acinetobacter baumannii, comprising:
- administering a therapeutically effective amount of a composition comprising sulbactam and ceftazidime to a subject in need thereof,
- wherein the amount of ceftazidime in the composition of sulbactam and ceftazidime is 10%-90% by mass of the amount of sulbactam.
Dependencies are inferred from the claim text.